EgyBrit Medical Centre
Cairo, 00202, Egypt
NCT Number: NCT04382495
The situation of COVID-19 pandemic creates many challenges for cancer patients and caregivers. Some modifications in cancer management have been evolved from cancer societies and organizations to support oncology professionals as much as possible to deliver optimal care to their cancer patients in such exceptional circumstances, and to protect patients from infection with COVID-19 as much as possible.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cairo, 00202, Egypt
In oncology practice during this pandemic, many cancer patients still feeling uncertainty about their cancer management and treatment outcome . The study is aiming to better understand the impact of the COVID-19 pandemic on cancer care from patients' and survivors' perspective.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
online survey
Time frame: one month
measured by online survey to understand the impact of COVID-19 pandemic on cancer care
El Zaitoun Specialized Hospital
Other Gov
Impact of COVID-19 Pandemic on Cancer Care Provision: a Cross-sectional Study of Egyptian Patients' Perspectives and Concerns
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04492410
COVID-19, Cancer
Nice, France
View Trial DetailsNCT04547634
COVID-19, Cancer
Málaga, Spain
View Trial DetailsNCT04442048
COVID-19, Cancer
Hamilton, Ontario, Canada
View Trial DetailsNCT04425616
Behavior, COVID
Southampton, United Kingdom
View Trial Details